2,824
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Steps to address anti-microbial drug resistance in today’s drug discovery

Pages 91-94 | Received 01 Oct 2018, Accepted 16 Nov 2018, Published online: 22 Nov 2018

References

  • World Health Organization. 2017. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. WHO/EMP/IAU/201712.
  • Payne DJ, Gwynn MN, Holmes DJ, et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 2006;6:29.
  • Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517:455.
  • Richter MF, Drown BS, Riley AP, et al. Predictive rules for compound accumulation yield a broad-spectrum antibiotic. Nature. 2017;545(7654):299–304.
  • Tängdén T. Combination antibiotic therapy for multidrug-resistant gram-negative bacteria. UPS J Med Sci. 2014;119(2):149–153.
  • Barbosa C, Beardmore R, Schulenburg H, et al. Antibiotic combination efficacy (ACE) networks for a pseudomonas aeruginosa model. PLoS Biol. 2018;16(4):e2004356.
  • Cokol M, Kuru N, Bicak E, et al. Efficient measurement and factorization of high-order drug interactions in mycobacterium tuberculosis. Sci Adv. 2017;3(10):e1701881.
  • Foster TJ. Antibiotic resistance in staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017;41(3):430–449.
  • Meylan S, Andrews IW, Collins JJ. Targeting antibiotic tolerance, pathogen by pathogen. Cell. 2018;172(6):1228–1238.
  • Palucci I, Delogu G. Host directed therapies for tuberculosis: futures strategies for an ancient disease. Chemotherapy. 2018;63(3):172–180.
  • Kakasis A, Panitsa G. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int J Antimicrob Agents. 2018 Sep 17. pii: S0924-8579(18)30263-2. doi:10.1016/j.ijantimicag.2018.09.004. [Epub ahead of print].
  • Chang RYK, Wallin M, Lin Y, et al. Phage therapy for respiratory infections. Adv Drug Deliv Rev. 2018;133:76–86.
  • Larsson DGJ. Antibiotics in the environment. Ups J Med Sci. 2014;119(2):108–112.
  • Pruden A, Larsson DGJ, Amézquita A, et al. Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect. 2013;121(8):878–885.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.